citalopram has been researched along with Body Weight in 49 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirthy-two female patients who had been diagnosed as having anorexia nervosa restricting subtype according to the DSM IV (Diagnostic and Statistical Manual of Mental Disorders-IV), were enrolled in a 6-month open trial with citalopram at a starting dose of 20 mg." | 9.08 | Citalopram in anorexia nervosa. ( Pallanti, S; Quercioli, L; Ramacciotti, A, 1997) |
| "Although we could not establish an association between the anxiety level of rats with either the onset or severity of LID, our results showed that citalopram was able to mediate a partial alleviation in LID after chronic treatment, and the extent of recovery was negatively correlated to the anxiety measures of individual animals." | 7.74 | The role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson's disease, and the effect of chronic treatment with the selective serotonin reuptake inhibitor citalopram. ( Barker, RA; Kuan, WL; Zhao, JW, 2008) |
| "The selective sigma2 (sigma2) ligand Lu 28-179, or 1'-[4[1-(4-fluorophenyl)-1H-indol-3-yl]-l-butyl]spiro[isobenzofuran++ +-1(3H),4'-piperidine], was studied in the chronic mild stress (CMS) model of depression." | 7.70 | The selective sigma2 ligand Lu 28-179 has an antidepressant-like profile in the rat chronic mild stress model of depression. ( Papp, M; Sánchez, C, 2000) |
| "Atherosclerosis is one of the most common disorders among the elderly." | 5.40 | Comparison of the effects of escitalopram and atorvastatin on diet-induced atherosclerosis in rats. ( Abdelbary, A; Hamza, M; Unis, A, 2014) |
| " To compare changes in body weight during treatment with different antidepressants, body weight and height were measured at baseline and after 6, 8, 12 and 26 wk treatment with escitalopram or nortriptyline in 630 adults with moderate-to-severe unipolar depression participating in GENDEP, a part-randomized open-label study." | 5.15 | Changes in body weight during pharmacological treatment of depression. ( Aitchison, KJ; Dernovsek, MZ; Farmer, A; Gray, JM; Hauser, J; Henigsberg, N; Kalember, P; Keers, R; Kozel, D; Larsen, ER; Maier, W; McGuffin, P; Mendlewicz, J; Mors, O; Placentino, A; Rietschel, M; Souery, D; Strohmaier, J; Szczepankiewicz, A; Uher, R; Zobel, A, 2011) |
| "Higher BMI and obesity predicted poor response to nortriptyline but did not significantly influence response to escitalopram." | 5.14 | Body weight as a predictor of antidepressant efficacy in the GENDEP project. ( Aitchison, KJ; Dernovsek, MZ; Farmer, A; Gunasinghe, C; Hauser, J; Henigsberg, N; Kalember, P; Kozel, D; Larsen, ER; Leszczynska-Rodziewicz, A; Linotte, S; Maier, W; McGuffin, P; Mors, O; Pedrini, L; Perroud, N; Placentino, A; Rietschel, M; Souery, D; Strohmaier, J; Uher, R; Zobel, A, 2009) |
| "Thirthy-two female patients who had been diagnosed as having anorexia nervosa restricting subtype according to the DSM IV (Diagnostic and Statistical Manual of Mental Disorders-IV), were enrolled in a 6-month open trial with citalopram at a starting dose of 20 mg." | 5.08 | Citalopram in anorexia nervosa. ( Pallanti, S; Quercioli, L; Ramacciotti, A, 1997) |
| "In this retrospective cohort study from participants in the Mayo Clinic RIGHT study who were prescribed citalopram, paroxetine, sertraline, or fluoxetine, our aim was to evaluate the association of metabolizer phenotype and total body weight after 6 months of SSRIs initiation." | 4.12 | Association between CYP metabolizer phenotypes and selective serotonin reuptake inhibitors induced weight gain: a retrospective cohort study. ( Acosta, A; Bielinski, SJ; Camilleri, M; Cifuentes, L; Decker, PA; Gonzalez-Izundegui, D; Hurtado, MD; Moyer, AM; Ricardo-Silgado, ML; Singh, S, 2022) |
| " Using imipramine and citalopram, we sought to assess which drug would be more appropriate as pharmacological reference in paradigms of depression in C57BL6N mice by measuring their effect on liquid consumption, home cage activity, body weight and long-term memory in naïve animals treated with each compound at generally used dose of 15 mg/kg/day." | 3.79 | The differential effects of chronic imipramine or citalopram administration on physiological and behavioral outcomes in naïve mice. ( Anokhin, K; Anthony, DC; Dolgov, O; Kubatiev, A; Schroeter, C; Steinbusch, HM; Strekalova, T, 2013) |
| " We examined whether treatment with a selective serotonin reuptake inhibitor [escitalopram (ESC)] could downregulate HPA axis activity and restore insulin sensitivity in LBW rats." | 3.76 | Treatment with an SSRI antidepressant restores hippocampo-hypothalamic corticosteroid feedback and reverses insulin resistance in low-birth-weight rats. ( Buhl, CS; Buhl, ES; Elfving, B; Jensen, TK; Jessen, N; Kristiansen, SB; Lund, S; Petersen, KF; Pold, R; Schmitz, O; Solskov, L; Wegener, G, 2010) |
| "Although we could not establish an association between the anxiety level of rats with either the onset or severity of LID, our results showed that citalopram was able to mediate a partial alleviation in LID after chronic treatment, and the extent of recovery was negatively correlated to the anxiety measures of individual animals." | 3.74 | The role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson's disease, and the effect of chronic treatment with the selective serotonin reuptake inhibitor citalopram. ( Barker, RA; Kuan, WL; Zhao, JW, 2008) |
| "A stress-induced decrease in sucrose preference in rodents is regarded as an analog of anhedonia, a key symptom of depression." | 3.73 | Selective effects of citalopram in a mouse model of stress-induced anhedonia with a control for chronic stress. ( Bartsch, D; Dolgov, O; Gorenkova, N; Schunk, E; Strekalova, T, 2006) |
| "Triiodothyronine (T3) has been shown to accelerate and potentiate the clinical response to tricyclic antidepressant (TCA) treatment in depressive disorders." | 3.71 | Chronic effects of triiodothyronine in combination with imipramine on 5-HT transporter, 5-HT(1A) and 5-HT(2A) receptors in adult rat brain. ( Jeanningros, R; Mazzola-Pomietto, P; Moreau, X, 2001) |
| "Corticosterone administration, which markedly reduced body weight gains and adrenal weights in both strains, increased Km and Vmax values in SHRs but decreased these values in WKY rats, compared to vehicle (2." | 3.71 | Effects of corticosterone ingestion on hippocampal [(3)H]serotonin reuptake in inbred rat strains. ( Chaouloff, F; Coomans, V; Fernandez, F; Mormede, P, 2001) |
| "The selective sigma2 (sigma2) ligand Lu 28-179, or 1'-[4[1-(4-fluorophenyl)-1H-indol-3-yl]-l-butyl]spiro[isobenzofuran++ +-1(3H),4'-piperidine], was studied in the chronic mild stress (CMS) model of depression." | 3.70 | The selective sigma2 ligand Lu 28-179 has an antidepressant-like profile in the rat chronic mild stress model of depression. ( Papp, M; Sánchez, C, 2000) |
| "Bupropion is presumed to be a dopamine-norepinephrine reuptake inhibitor and is an effective antidepressant." | 2.44 | Bupropion: a review of its use in the management of major depressive disorder. ( Curran, MP; Dhillon, S; Yang, LP, 2008) |
| "Escitalopram treatment significantly decreased PAI-1 levels in the serum, but not in the CSF." | 1.43 | Plasminogen Activator Inhibitor-1 in depression: Results from Animal and Clinical Studies. ( Chen, S; Jiang, H; Li, X; Liang, J; Lu, N; Yuan, Y; Yue, Y; Zhang, Z, 2016) |
| "Atherosclerosis is one of the most common disorders among the elderly." | 1.40 | Comparison of the effects of escitalopram and atorvastatin on diet-induced atherosclerosis in rats. ( Abdelbary, A; Hamza, M; Unis, A, 2014) |
| "Escitalopram treatment decreased anxiety-related behaviours in stressed animals, by increasing the time spent in the central part of the arena with respect to saline treated stressed animals, without affecting exploratory related behaviours." | 1.40 | Behavioural and transcriptional effects of escitalopram in the chronic escape deficit model of depression. ( Alboni, S; Benatti, C; Blom, JM; Brunello, N; Gandolfi, F; Mendlewicz, J; Tascedda, F, 2014) |
| "The citalopram-treated male mice showed altered sexual behavior, specifically a significant reduction in the number of intromissions preceding ejaculation compared with the vehicle-treated mice." | 1.38 | Early-life citalopram-induced impairments in sexual behavior and the role of androgen receptor. ( Parhar, IS; Putteeraj, M; Soga, T; Song, KP; Wong, DW, 2012) |
| "Escitalopram (ES-CIT) is a widely used, highly specific antidepressant." | 1.35 | Effects of escitalopram on the regulation of brain-derived neurotrophic factor and nerve growth factor protein levels in a rat model of chronic stress. ( Abumaria, N; Danker-Hopfe, H; Fuchs, E; Hellweg, R; Hiemke, C; Schulte-Herbrüggen, O; Ziegler, A, 2009) |
| "Citalopram pretreatment blocked MDMA-related reductions in aggressive and exploratory behavior measured in the social interaction and hole-board tests respectively." | 1.35 | Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram. ( Ali, SF; Fraiman, JB; Meyer, JS; Owens, CB; Piper, BJ, 2008) |
| "This 6-week, open-label, multicenter study evaluated the efficacy and safety of quetiapine in combination with citalopram in adult patients (n=25) with ICD-10/DSM-IV unipolar psychotic depression." | 1.34 | Quetiapine in combination with citalopram in patients with unipolar psychotic depression. ( Aschauer, H; Hrubos, W; Kasper, S; Konstantinidis, A; Lehofer, M; Nirnberger, G; Windhager, E, 2007) |
| "Citalopram was retested 18 weeks after the first treatment during 1 week, with continuous access to ethanol; 10 mg/kg had no effect and 40 mg/kg decreased ethanol intake at day 1, reaching a minimum in day 3." | 1.30 | Citalopram as an inhibitor of voluntary ethanol intake in the male rat. ( Hedlund, L; Wahlström, G, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (14.29) | 18.2507 |
| 2000's | 19 (38.78) | 29.6817 |
| 2010's | 20 (40.82) | 24.3611 |
| 2020's | 3 (6.12) | 2.80 |
| Authors | Studies |
|---|---|
| Ricardo-Silgado, ML | 1 |
| Singh, S | 1 |
| Cifuentes, L | 1 |
| Decker, PA | 1 |
| Gonzalez-Izundegui, D | 1 |
| Moyer, AM | 1 |
| Hurtado, MD | 1 |
| Camilleri, M | 1 |
| Bielinski, SJ | 1 |
| Acosta, A | 1 |
| Puzhko, S | 1 |
| Aboushawareb, SAE | 1 |
| Kudrina, I | 1 |
| Schuster, T | 1 |
| Barnett, TA | 1 |
| Renoux, C | 1 |
| Bartlett, G | 1 |
| Henn, L | 1 |
| Zanta, NC | 1 |
| Girardi, CEN | 1 |
| Suchecki, D | 1 |
| Hale, MW | 1 |
| Lukkes, JL | 1 |
| Dady, KF | 1 |
| Kelly, KJ | 1 |
| Paul, ED | 1 |
| Smith, DG | 1 |
| Raison, CL | 1 |
| Lowry, CA | 1 |
| Pinheiro, IL | 1 |
| da Silva, AI | 1 |
| Reginato, A | 1 |
| da Silva Filho, RC | 1 |
| Galindo, LCM | 1 |
| Matos, RJB | 1 |
| de Souza Ferraz, JC | 1 |
| Toscano Meneses da Silva Castro, AE | 1 |
| Milanski Ferreira, M | 1 |
| Manhães de Castro, R | 2 |
| de Souza, SL | 1 |
| Strekalova, T | 2 |
| Anthony, DC | 1 |
| Dolgov, O | 2 |
| Anokhin, K | 1 |
| Kubatiev, A | 1 |
| Steinbusch, HM | 1 |
| Schroeter, C | 1 |
| Gupta, D | 1 |
| Kurhe, Y | 2 |
| Radhakrishnan, M | 1 |
| Unis, A | 1 |
| Abdelbary, A | 1 |
| Hamza, M | 1 |
| Benatti, C | 1 |
| Alboni, S | 1 |
| Blom, JM | 1 |
| Gandolfi, F | 1 |
| Mendlewicz, J | 2 |
| Brunello, N | 1 |
| Tascedda, F | 1 |
| Lin, DH | 1 |
| Zhang, XR | 1 |
| Ye, DQ | 1 |
| Xi, GJ | 1 |
| Hui, JJ | 1 |
| Liu, SS | 1 |
| Li, LJ | 1 |
| Zhang, ZJ | 2 |
| Li, XL | 1 |
| Yuan, YG | 1 |
| Xu, H | 1 |
| Wu, D | 1 |
| Gong, WG | 1 |
| Geng, LY | 1 |
| Wu, FF | 1 |
| Tang, H | 1 |
| Xu, L | 1 |
| Mahesh, R | 1 |
| Liang, S | 1 |
| Wang, T | 1 |
| Hu, X | 1 |
| Luo, J | 1 |
| Li, W | 1 |
| Wu, X | 1 |
| Duan, Y | 1 |
| Jin, F | 1 |
| Jiang, H | 1 |
| Li, X | 1 |
| Chen, S | 1 |
| Lu, N | 1 |
| Yue, Y | 1 |
| Liang, J | 1 |
| Zhang, Z | 1 |
| Yuan, Y | 1 |
| Sprowles, JL | 1 |
| Hufgard, JR | 1 |
| Gutierrez, A | 1 |
| Bailey, RA | 1 |
| Jablonski, SA | 1 |
| Williams, MT | 2 |
| Vorhees, CV | 2 |
| Bjørnebekk, A | 1 |
| Mathé, AA | 2 |
| Gruber, SH | 1 |
| Brené, S | 1 |
| Uher, R | 2 |
| Mors, O | 2 |
| Hauser, J | 2 |
| Rietschel, M | 2 |
| Maier, W | 2 |
| Kozel, D | 2 |
| Henigsberg, N | 2 |
| Souery, D | 2 |
| Placentino, A | 2 |
| Perroud, N | 1 |
| Dernovsek, MZ | 2 |
| Strohmaier, J | 2 |
| Larsen, ER | 2 |
| Zobel, A | 2 |
| Leszczynska-Rodziewicz, A | 1 |
| Kalember, P | 2 |
| Pedrini, L | 1 |
| Linotte, S | 1 |
| Gunasinghe, C | 1 |
| Aitchison, KJ | 2 |
| McGuffin, P | 2 |
| Farmer, A | 2 |
| Schulte-Herbrüggen, O | 1 |
| Fuchs, E | 1 |
| Abumaria, N | 1 |
| Ziegler, A | 1 |
| Danker-Hopfe, H | 1 |
| Hiemke, C | 1 |
| Hellweg, R | 1 |
| Jin, Y | 1 |
| Pollock, BG | 1 |
| Frank, E | 1 |
| Cassano, GB | 1 |
| Rucci, P | 1 |
| Müller, DJ | 1 |
| Kennedy, JL | 1 |
| Forgione, RN | 1 |
| Kirshner, M | 1 |
| Kepple, G | 1 |
| Fagiolini, A | 1 |
| Kupfer, DJ | 1 |
| Bies, RR | 1 |
| Buhl, ES | 1 |
| Jensen, TK | 1 |
| Jessen, N | 1 |
| Elfving, B | 1 |
| Buhl, CS | 1 |
| Kristiansen, SB | 1 |
| Pold, R | 1 |
| Solskov, L | 1 |
| Schmitz, O | 1 |
| Wegener, G | 1 |
| Lund, S | 1 |
| Petersen, KF | 1 |
| Keers, R | 1 |
| Gray, JM | 1 |
| Szczepankiewicz, A | 1 |
| Mikrouli, E | 1 |
| Wörtwein, G | 1 |
| Soylu, R | 1 |
| Petersén, Å | 1 |
| Młyniec, K | 1 |
| Nowak, G | 1 |
| Soga, T | 1 |
| Wong, DW | 1 |
| Putteeraj, M | 1 |
| Song, KP | 1 |
| Parhar, IS | 1 |
| Flandreau, EI | 1 |
| Bourke, CH | 1 |
| Ressler, KJ | 1 |
| Vale, WW | 1 |
| Nemeroff, CB | 1 |
| Owens, MJ | 1 |
| Schaefer, TL | 1 |
| Grace, CE | 1 |
| Braun, AA | 1 |
| Amos-Kroohs, RM | 1 |
| Graham, DL | 1 |
| Skelton, MR | 1 |
| Fassino, S | 1 |
| Leombruni, P | 1 |
| Daga, G | 1 |
| Brustolin, A | 1 |
| Migliaretti, G | 1 |
| Cavallo, F | 1 |
| Rovera, G | 1 |
| Kugelberg, FC | 2 |
| Apelqvist, G | 2 |
| Bengtsson, F | 2 |
| Pallanti, S | 1 |
| Quercioli, L | 1 |
| Ramacciotti, A | 1 |
| Allard, P | 1 |
| Gram, L | 1 |
| Timdahl, K | 1 |
| Behnke, K | 1 |
| Hanson, M | 1 |
| Søgaard, J | 1 |
| Maciag, D | 1 |
| Simpson, KL | 1 |
| Coppinger, D | 1 |
| Lu, Y | 1 |
| Wang, Y | 1 |
| Lin, RC | 1 |
| Paul, IA | 1 |
| Gorenkova, N | 1 |
| Schunk, E | 1 |
| Bartsch, D | 1 |
| Konstantinidis, A | 1 |
| Hrubos, W | 1 |
| Nirnberger, G | 1 |
| Windhager, E | 1 |
| Lehofer, M | 1 |
| Aschauer, H | 1 |
| Kasper, S | 1 |
| Piper, BJ | 1 |
| Fraiman, JB | 1 |
| Owens, CB | 1 |
| Ali, SF | 1 |
| Meyer, JS | 1 |
| Kuan, WL | 1 |
| Zhao, JW | 1 |
| Barker, RA | 1 |
| Dhillon, S | 1 |
| Yang, LP | 1 |
| Curran, MP | 1 |
| Cabrera, TM | 1 |
| Levy, AD | 1 |
| Li, Q | 1 |
| van de Kar, LD | 1 |
| Battaglia, G | 1 |
| Bouwer, CD | 1 |
| Harvey, BH | 1 |
| Izumi, J | 1 |
| Washizuka, M | 1 |
| Hayashi-Kuwabara, Y | 1 |
| Yoshinaga, K | 1 |
| Tanaka, Y | 1 |
| Ikeda, Y | 1 |
| Kiuchi, Y | 1 |
| Oguchi, K | 1 |
| Kulikov, A | 1 |
| Mormède, P | 2 |
| Chaouloff, F | 2 |
| Hedlund, L | 1 |
| Wahlström, G | 1 |
| Keeney, AJ | 1 |
| Hogg, S | 1 |
| Sánchez, C | 1 |
| Papp, M | 1 |
| Barreto Medeiros, JM | 1 |
| Mendes da Silva, C | 1 |
| Ferreira, LM | 1 |
| Guedes, RC | 2 |
| Cabral Filho, JE | 1 |
| Costa, JA | 2 |
| Carlsson, B | 1 |
| Ahlner, J | 1 |
| Moreau, X | 1 |
| Jeanningros, R | 1 |
| Mazzola-Pomietto, P | 1 |
| Medeiros, JM | 1 |
| Silva, CM | 1 |
| Sougey, EB | 1 |
| Castro, CM | 1 |
| Castro, RM | 1 |
| Fernandez, F | 1 |
| Coomans, V | 1 |
| Amâncio-Dos-Santos, A | 1 |
| Manhães-De-Castro, R | 1 |
| Costa-Cruz, RR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Examining Immune-Based Mechanisms of Action for Mild-Intensity Whole Body Hyperthermia (WBH) in the Treatment of Major Depressive Disorder[NCT03787290] | Phase 2 | 35 participants (Anticipated) | Interventional | 2023-12-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for citalopram and Body Weight
| Article | Year |
|---|---|
Excess body weight as a predictor of response to treatment with antidepressants in patients with depressive disorder.
Topics: Adult; Antidepressive Agents; Body Weight; Citalopram; Depressive Disorder; Humans; Nortriptyline | 2020 |
Bupropion: a review of its use in the management of major depressive disorder.
Topics: Antidepressive Agents, Second-Generation; Body Weight; Bupropion; Citalopram; Delayed-Action Prepara | 2008 |
7 trials available for citalopram and Body Weight
| Article | Year |
|---|---|
Body weight as a predictor of antidepressant efficacy in the GENDEP project.
Topics: Adult; Affect; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Appetite; | 2009 |
Effect of age, weight, and CYP2C19 genotype on escitalopram exposure.
Topics: Adult; Age Factors; Aged; Alleles; Antidepressive Agents, Second-Generation; Aryl Hydrocarbon Hydrox | 2010 |
Changes in body weight during pharmacological treatment of depression.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Body Mass Index; Body Weight; Citalopram; Depressive | 2011 |
Efficacy of citalopram in anorexia nervosa: a pilot study.
Topics: Adolescent; Adult; Ambulatory Care; Anorexia Nervosa; Body Mass Index; Body Weight; Citalopram; Fema | 2002 |
Citalopram in anorexia nervosa.
Topics: Adolescent; Adult; Anorexia Nervosa; Body Mass Index; Body Weight; Citalopram; Female; Humans; Selec | 1997 |
Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Second-Generation; Body Weigh | 2004 |
Phasic craving for carbohydrate observed with citalopram.
Topics: Adolescent; Adult; Body Weight; Citalopram; Depressive Disorder; Dietary Carbohydrates; Female; Huma | 1996 |
40 other studies available for citalopram and Body Weight
| Article | Year |
|---|---|
Association between CYP metabolizer phenotypes and selective serotonin reuptake inhibitors induced weight gain: a retrospective cohort study.
Topics: Body Weight; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; | 2022 |
Chronic Escitalopram Treatment Does Not Alter the Effects of Neonatal Stress on Hippocampal BDNF Levels, 5-HT
Topics: Aging; Animals; Animals, Newborn; Behavior, Animal; Body Weight; Brain-Derived Neurotrophic Factor; | 2021 |
Whole-body hyperthermia and a subthreshold dose of citalopram act synergistically to induce antidepressant-like behavioral responses in adolescent rats.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Body Temperature; Body Weight; Citalopram; Dep | 2017 |
Neonatal fluoxetine exposure modulates serotonergic neurotransmission and disturb inhibitory action of serotonin on food intake.
Topics: Age Factors; Animals; Animals, Newborn; Body Weight; Citalopram; Eating; Female; Fluoxetine; Food De | 2019 |
The differential effects of chronic imipramine or citalopram administration on physiological and behavioral outcomes in naïve mice.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Body Weight; Cita | 2013 |
Antidepressant effects of insulin in streptozotocin induced diabetic mice: Modulation of brain serotonin system.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Blood Glucose; Body Weight | 2014 |
Comparison of the effects of escitalopram and atorvastatin on diet-induced atherosclerosis in rats.
Topics: Animals; Aorta, Abdominal; Atherosclerosis; Atorvastatin; Body Weight; Citalopram; Diet, High-Fat; H | 2014 |
Behavioural and transcriptional effects of escitalopram in the chronic escape deficit model of depression.
Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Body Weight; Chronic Disease; Citalopram | 2014 |
The Role of the Two-Pore Domain Potassium Channel TREK-1 in the Therapeutic Effects of Escitalopram in a Rat Model of Poststroke Depression.
Topics: Animals; Body Weight; Brain; Cell Proliferation; Citalopram; Depression; Disease Models, Animal; Exp | 2015 |
Changed Synaptic Plasticity in Neural Circuits of Depressive-Like and Escitalopram-Treated Rats.
Topics: Animals; Antidepressive Agents; Blotting, Western; Body Weight; Brain; Chronic Disease; Citalopram; | 2015 |
Ondansetron attenuates co-morbid depression and anxiety associated with obesity by inhibiting the biochemical alterations and improving serotonergic neurotransmission.
Topics: Animals; Anxiety; Behavior, Animal; Body Weight; Brain; Citalopram; Corticosterone; Depression; Diet | 2015 |
Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress.
Topics: Adrenocorticotropic Hormone; Animals; Anxiety; Behavior, Animal; Body Weight; Brain-Derived Neurotro | 2015 |
Plasminogen Activator Inhibitor-1 in depression: Results from Animal and Clinical Studies.
Topics: Animals; Behavior, Animal; Body Weight; Case-Control Studies; Chronic Disease; Citalopram; Depressio | 2016 |
Perinatal exposure to the selective serotonin reuptake inhibitor citalopram alters spatial learning and memory, anxiety, depression, and startle in Sprague-Dawley rats.
Topics: Age Factors; Amphetamines; Animals; Animals, Newborn; Anxiety; Body Weight; Citalopram; Depression; | 2016 |
Housing conditions modulate escitalopram effects on antidepressive-like behaviour and brain neurochemistry.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Body Weight; Brain Chemistry; C | 2008 |
Effects of escitalopram on the regulation of brain-derived neurotrophic factor and nerve growth factor protein levels in a rat model of chronic stress.
Topics: Adrenal Glands; Animals; Antidepressive Agents, Second-Generation; Body Weight; Brain; Brain-Derived | 2009 |
Treatment with an SSRI antidepressant restores hippocampo-hypothalamic corticosteroid feedback and reverses insulin resistance in low-birth-weight rats.
Topics: Adrenocorticotropic Hormone; Analysis of Variance; Animals; Area Under Curve; Blood Glucose; Body We | 2010 |
Increased numbers of orexin/hypocretin neurons in a genetic rat depression model.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Body Weight; Citalopram; Depres | 2011 |
Zinc deficiency induces behavioral alterations in the tail suspension test in mice. Effect of antidepressants.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Body Weight; Citalopram; Depression; Drug Resistan | 2012 |
Early-life citalopram-induced impairments in sexual behavior and the role of androgen receptor.
Topics: Animals; Animals, Newborn; Antidepressive Agents, Second-Generation; Body Weight; Citalopram; Disord | 2012 |
Escitalopram alters gene expression and HPA axis reactivity in rats following chronic overexpression of corticotropin-releasing factor from the central amygdala.
Topics: Amygdala; Animals; Anxiety; Behavior, Animal; Body Weight; Citalopram; Corticotropin-Releasing Hormo | 2013 |
Cognitive impairments from developmental exposure to serotonergic drugs: citalopram and MDMA.
Topics: Animals; Animals, Newborn; Body Weight; Citalopram; Cognition Disorders; Disease Models, Animal; Fem | 2013 |
Effects of chronic citalopram treatment on central and peripheral spontaneous open-field behaviours in rats.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Body Weight; Brain; Circadian R | 2002 |
Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry.
Topics: Animals; Animals, Newborn; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antigens, Nuclea | 2006 |
Selective effects of citalopram in a mouse model of stress-induced anhedonia with a control for chronic stress.
Topics: Animals; Body Weight; Chronic Disease; Citalopram; Depression; Drinking; Hindlimb Suspension; Immers | 2006 |
Quetiapine in combination with citalopram in patients with unipolar psychotic depression.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Aged; Antidepressive Agents; Antipsychotic Agents | 2007 |
Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram.
Topics: Analysis of Variance; Animals; Behavior, Animal; Body Temperature; Body Weight; Brain Chemistry; Cit | 2008 |
The role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson's disease, and the effect of chronic treatment with the selective serotonin reuptake inhibitor citalopram.
Topics: Adrenal Cortex Hormones; Amphetamine; Animals; Anxiety; Blotting, Western; Body Weight; Central Nerv | 2008 |
Prenatal methamphetamine attenuates serotonin mediated renin secretion in male and female rat progeny: evidence for selective long-term dysfunction of serotonin pathways in brain.
Topics: Analysis of Variance; Animals; Body Weight; Brain; Cerebral Cortex; Citalopram; Female; Hypothalamus | 1993 |
Protective effect of citalopram against the attenuation of the alpha 1-potentiation of cAMP formation in Fischer 344 strain rats.
Topics: Adrenergic Uptake Inhibitors; Animals; Behavior, Animal; Body Weight; Brain Chemistry; Citalopram; C | 1997 |
Effects of adrenalectomy and corticosterone replacement on diurnal [3H]citalopram binding in rat midbrain.
Topics: Adrenalectomy; Adrenocorticotropic Hormone; Animals; Anti-Inflammatory Agents; Body Weight; Carrier | 1997 |
Citalopram as an inhibitor of voluntary ethanol intake in the male rat.
Topics: Alcoholism; Animals; Body Weight; Citalopram; Drinking; Drug Tolerance; Ethanol; Male; Rats; Rats, S | 1998 |
Behavioural consequences of repeated social defeat in the mouse: preliminary evaluation of a potential animal model of depression.
Topics: Aggression; Alcohol Drinking; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; B | 1999 |
The selective sigma2 ligand Lu 28-179 has an antidepressant-like profile in the rat chronic mild stress model of depression.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricy | 2000 |
Reduction of intraspecific aggression in adult rats by neonatal treatment with a selective serotonin reuptake inhibitor.
Topics: Aggression; Animals; Animals, Newborn; Body Weight; Citalopram; Male; Random Allocation; Rats; Rats, | 2001 |
In vivo steady-state pharmacokinetic outcome following clinical and toxic doses of racemic citalopram to rats.
Topics: Animals; Behavior, Animal; Biotransformation; Body Weight; Brain; Citalopram; Drug Implants; Male; R | 2001 |
Chronic effects of triiodothyronine in combination with imipramine on 5-HT transporter, 5-HT(1A) and 5-HT(2A) receptors in adult rat brain.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antidepressive Agents, Tricyclic; Body Weight; Brai | 2001 |
Action of selective serotonin reuptake inhibitor on aggressive behavior in adult rat submitted to the neonatal malnutrition.
Topics: Aggression; Animals; Animals, Suckling; Behavior, Animal; Body Weight; Brain; Citalopram; Diet; Fema | 2001 |
Effects of corticosterone ingestion on hippocampal [(3)H]serotonin reuptake in inbred rat strains.
Topics: Adrenal Glands; Animals; Body Weight; Carrier Proteins; Citalopram; Corticosterone; Hippocampus; Mal | 2001 |
Citalopram has an antagonistic action on cortical spreading depression in well-nourished and early-malnourished adult rats.
Topics: Animals; Body Weight; Citalopram; Cortical Spreading Depression; Injections, Intraperitoneal; Male; | 2002 |